Close Menu

DARPA

Duality will apply homomorphic encryption to data from multiple sources to train machine learning while safeguarding the privacy of individual patients.

Single-cell analysis, next-generation sequencing, and synthetic DNA have all been crucial to efforts to find antibodies that could neutralize SARS-CoV-2.

The firm is part of a research consortium that is led by Mount Sinai and includes Fluidigm to develop a device to detect epigenetic signatures of WMD exposure.

Fluidigm will develop a microfluidic device for single-cell measurement of epigenetic changes under a broader $27.8 million DARPA-funded project.

The grant was awarded as part of DARPA's Epigenetic Characterization and Observation program, which aims to develop new approaches to epigenetic analysis.

The researchers are aiming to find molecular signatures in blood that identify previous exposures to materials associated with weapons of mass destruction.

With CRISPR being applied to a range of biological problems, researchers are searching for ways to stop its edits, Technology Review reports.

DARPA is working on developing algorithms that gauge the credibility of research findings, Wired reports.

Scientists say that a DARPA project to use bugs to modify plant genes could be viewed as a bioweapon, the Associated Press reports.

The award expands an existing collaboration between the firms for automated organism design.

Pages

AstraZeneca has released its coronavirus vaccine trial protocol, according to the New York Times.

Time magazine looks into how liquid biopsies are changing cancer care.

According to the Guardian, more than 150 countries have signed on to a global SARS-CoV-2 vaccine plan.

In PNAS this week: similar muscle protein patterns across hypertrophic cardiomyopathy phenotypes, analysis of gene expression and brain anatomy in major depression, and more.